Judge OKs $900M Biogen False Claims Settlement Involving Kickbacks For 3 MS Drugs
BOSTON — A Massachusetts federal judge gave final approval to a previously disclosed $900 million settlement by Biogen Inc. of a whistleblower lawsuit alleging the pharmaceutical company paid kickbacks to induce...To view the full article, register now.
Already a subscriber? Click here to view full article